Respiratory Research

official impact factor 2.86

Open Access Highly Access Research

Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis

Cecilia K Andersson1, Annika Andersson-Sjöland2, Michiko Mori2, Oskar Hallgren2, Annie Pardo3, Leif Eriksson1, Leif Bjermer1, Claes-Göran Löfdahl1, Moises Selman4, Gunilla Westergren-Thorsson2 and Jonas S Erjefält2*

Author Affiliations

1 Dept of Respiratory Medicine and Allergology, Lund University, Klinikgatan 30, 221 84 Lund, Sweden

2 Dept of Exp Medical Science, Lund University, Klinikgatan 30, 221 84 Lund, Sweden

3 Faculty of Sciences, Universidad Nacional Autónoma de México, Avenida Universidad 3000; CP 04510 Mexico DF, México

4 Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Tlalpan 4502; CP 14080, México DF, México

For all author emails, please log on.

Respiratory Research 2011, 12:139 doi:10.1186/1465-9921-12-139

Published: 20 October 2011

Abstract

Background

Although mast cells are regarded as important regulators of inflammation and tissue remodelling, their role in cystic fibrosis (CF) and idiopathic pulmonary fibrosis (IPF) has remained less studied. This study investigates the densities and phenotypes of mast cell populations in multiple lung compartments from patients with CF, IPF and never smoking controls.

Methods

Small airways, pulmonary vessels, and lung parenchyma were subjected to detailed immunohistochemical analyses using lungs from patients with CF (20 lung regions; 5 patients), IPF (21 regions; 7 patients) and controls (16 regions; 8 subjects). In each compartment the densities and distribution of MCT and MCTC mast cell populations were studied as well as the mast cell expression of IL-6 and TGF-β.

Results

In the alveolar parenchyma in lungs from patients with CF, MCTC numbers increased in areas showing cellular inflammation or fibrosis compared to controls. Apart from an altered balance between MCTC and MCT cells, mast cell in CF lungs showed elevated expression of IL-6. In CF, a decrease in total mast cell numbers was observed in small airways and pulmonary vessels. In patients with IPF, a significantly elevated MCTC density was present in fibrotic areas of the alveolar parenchyma with increased mast cell expression of TGF-β. The total mast cell density was unchanged in small airways and decreased in pulmonary vessels in IPF. Both the density, as well as the percentage, of MCTC correlated positively with the degree of fibrosis. The increased density of MCTC, as well as MCTC expression of TGF-β, correlated negatively with patient lung function.

Conclusions

The present study reveals that altered mast cell populations, with increased numbers of MCTC in diseased alveolar parenchyma, represents a significant component of the histopathology in CF and IPF. The mast cell alterations correlated to the degree of tissue remodelling and to lung function parameters. Further investigations of mast cells in these diseases may open for new therapeutic strategies.

Keywords:
mast cell; connective tissue mast cell; cystic fibrosis; idiopathic pulmonary fibrosis; alveolar parenchyma; remodelling; fibrosis